Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
ConditionAdolescent Behavior
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-29
SponsorStanford University
About this trial
The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age (15-29 years)
Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year)
Speaks English
Reads English
Disqualifiers
Unable to participate in study due to developmental delay or developmental disorder
Trial design
Design model
Single group
Treatments tested in this trial
Clinical Decision-Making Scenarios and Preferences Assessment
BehavioralParticipants complete a socio-demographic questionnaire and decision-making preferences scale, including hypothetical clinical scenarios, to identify their preferred decision-making role (active, collaborative, or passive) and the influence of providers or family. Delivered electronically via secure link; reminders sent as needed.
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: AYA Decision-Making Role AssessmentExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Distribution of Decision-Making Roles in Clinical Scenarios
Proportion of participants who select an active, collaborative, or passive role in hypothetical clinical decision-making scenarios. Each role will be counted and compared across participant subgroups.
Time frame
Within 2 weeks of survey link deliverySecondary outcomes
1
Association Between Sociodemographic Characteristics and Decision-Making Role
This outcome assesses the association between sociodemographic characteristics (e.g., age, race/ethnicity, gender, education level, and employment status) and adolescents' and young adults' preferred treatment decision-making role. Role preference (active, collaborative, or passive) is assessed using the modified Control Preferences Scale. Sociodemographic variables are self-reported via electronic questionnaire. The unit of measure is the chi-square test statistic or ANOVA output, depending on the variable type.
Time frame
At time of electronic survey completion2
Concordance Between Interview Responses and Scenario-Based Decision-Making Roles
Proportion of interview responses that align with or differ from role preferences identified in hypothetical scenarios. Qualitative responses will be coded and categorized into roles for comparison.
Time frame
At time of interview, within 4 weeks of survey completion3
Correlation Between Healthcare Encounters and Decision-Making Role Preference
This outcome measures the correlation between the number of cancer-related healthcare encounters and adolescents' and young adults' preferred treatment decision-making role. Healthcare encounters will be abstracted from the electronic health record and include clinic visits, procedures, hospitalizations, ICU stays, and emergency department visits. Decision-making role preference (active, collaborative, or passive) will be assessed using the modified Control Preferences Scale. The unit of measure is the Pearson correlation coefficient.
Time frame
At time of interview, within 4 weeks of survey completionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov